What is aTyr Pharma's G&A?

aTyr Pharma (ATYR) reported G&A of $4.12M in Q1 2026.

How has aTyr Pharma's G&A changed year-over-year?

aTyr Pharma's G&A increased by 4.0% year-over-year, from $3.96M to $4.12M.

What is the long-term trend for aTyr Pharma's G&A?

Over 4 years (2021 to 2025), aTyr Pharma's G&A has grown at a 13.1% compound annual growth rate (CAGR), from $10.75M to $17.6M.

Overhead costs not directly tied to production or sales — corporate management, legal, accounting, office rent, insurance, and other administrative functions.

aTyr Pharma ATYR G&A

G&A at other companies

Design Therapeutics, Inc.DSGN

$5.33M+5.7%

CytomX TherapeuticsCTMX

$10.69M+13.4%

Vor BiopharmaVOR

$17.57M+167%

Oric Pharmaceuticals, Inc.ORIC

$8.18M+1.3%

Syndax PharmaceuticalsSNDX

$37.59M-8.4%

Gyre Therapeutics, Inc.GYRE

$7.22M+45.7%

Other financials

Income statement

See full

Revenue-—

Operating income-$11.4M+27.5%

Net income-$10.8M+27.5%

EPS (diluted)-$0.11+35.3%

Balance sheet

See full

Cash & equivalents$10.0M-3.4%

Total debt$12.3M-9.2%

Total equity$57.9M-22.8%

Total assets$79.7M-18.1%

Cash flow

See full

Operating cash flow-$12.5M+18.8%

CapEx$138.0K—

Free cash flow-$12.7M+17.9%

Valuation

See full

Market cap$54.88M-88.2%

Enterprise value$57.17M—

P/S288.8×—

Profitability

See full

Operating margin-40,856.3%+28,833pp

Net margin-39,009.5%+29,653pp

FCF margin-32,664.7%+4,018pp

Returns & leverage

See full

Return on equity-105.3%+50.6pp

Debt / equity0.2×0.0×

Current ratio5.8×-2.0×

Where this comes from

Reported directly by aTyr Pharma in its filing.

Tagged under the XBRL concept us-gaap:GeneralAndAdministrativeExpense.

The official record: aTyr Pharma’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about aTyr Pharma's g&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is aTyr Pharma's G&A?: aTyr Pharma (ATYR) reported G&A of $4.12M in Q1 2026.
How has aTyr Pharma's G&A changed year-over-year?: aTyr Pharma's G&A increased by 4.0% year-over-year, from $3.96M to $4.12M.
What is the long-term trend for aTyr Pharma's G&A?: Over 4 years (2021 to 2025), aTyr Pharma's G&A has grown at a 13.1% compound annual growth rate (CAGR), from $10.75M to $17.6M.
What does G&A mean?: Overhead costs not directly tied to production or sales — corporate management, legal, accounting, office rent, insurance, and other administrative functions.